Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.45 USD | +7.19% | -4.73% | -39.13% |
May. 09 | Pulse Biosciences, Inc. Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System | CI |
May. 07 | Transcript : Pulse Biosciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Neutral |
Resistance | 8.050 | 12.84 | 12.66 |
Spread/Res. | -7.45% | -41.98% | -41.15% |
Spread/Supp. | +11.36% | +61.08% | +84.86% |
Support | 6.690 | 4.625 | 4.030 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- PLSE Stock
- Charts Pulse Biosciences, Inc.